Mimedx Group Inc (MDXG)

$3.56 +0.01 (0.28%)
Market Cap 524.29M
Revenue (ttm) 418.63M
Net Income (ttm) 48.58M
EPS (ttm) N/A
PE Ratio 10.41
Forward PE N/A
Profit Margin 11.60%
Debt to Equity Ratio 0.01
Volume 1,221,100
Avg Vol 1,526,362
Day's Range N/A - N/A
Shares Out 148.95M
Stochastic %K 36%
Beta 1.46
Analysts Strong Sell
Price Target $6.50

Company Profile

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors. Its patented and proprietary processing method employs aseptic processing techni...

Industry: Biotechnology
Sector: Healthcare
Phone: 770 651 9100
Address:
1775 West Oak Commons Court, NE, Marietta, United States
Mobagri
Mobagri May. 15 at 4:32 AM
$MDXG this guy has no business being here. He was hired in 2023 to be PR for this losing company
2 · Reply
WarrenDouglasTrader
WarrenDouglasTrader May. 14 at 8:38 PM
$MDXG Legislative changes are coming.
0 · Reply
Monticello4
Monticello4 May. 14 at 7:49 PM
$MDXG ...-=
0 · Reply
Monticello4
Monticello4 May. 14 at 7:48 PM
$MDXG ===
0 · Reply
Monticello4
Monticello4 May. 14 at 7:45 PM
$MDXG .....
0 · Reply
Monticello4
Monticello4 May. 14 at 7:45 PM
$MDXG -.-
0 · Reply
Monticello4
Monticello4 May. 14 at 7:44 PM
$MDXG #
0 · Reply
Monticello4
Monticello4 May. 14 at 7:44 PM
$MDXG -
0 · Reply
Monticello4
Monticello4 May. 14 at 7:43 PM
$MDXG +dxcm
0 · Reply
Monticello4
Monticello4 May. 14 at 7:43 PM
$MDXG -=-
0 · Reply
Latest News on MDXG
MIMEDX Announces Launch of G4Derm® Plus

May 8, 2026, 8:00 AM EDT - 7 days ago

MIMEDX Announces Launch of G4Derm® Plus

MiMedx price target lowered to $6 from $7 at Craig-Hallum

2026-04-30T15:00:20.000Z - 15 days ago

MiMedx price target lowered to $6 from $7 at Craig-Hallum

MiMedx price target lowered to $6 from $7 at Citizens

2026-04-30T09:56:05.000Z - 15 days ago

MiMedx price target lowered to $6 from $7 at Citizens

MiMedx reports Q1 adjusted EPS (5c), consensus (4c)

2026-04-29T20:49:58.000Z - 16 days ago

MiMedx reports Q1 adjusted EPS (5c), consensus (4c)

MiMedx Group Earnings Call Transcript: Q1 2026

Apr 29, 2026, 4:30 PM EDT - 16 days ago

MiMedx Group Earnings Call Transcript: Q1 2026

MIMEDX Announces First Quarter 2026 Operating & Financial Results

Apr 29, 2026, 4:01 PM EDT - 16 days ago

MIMEDX Announces First Quarter 2026 Operating & Financial Results

MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29

Apr 22, 2026, 8:00 AM EDT - 23 days ago

MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29

MiMedx price target lowered to $7 from $10 at Citizens

2026-04-20T09:40:37.000Z - 25 days ago

MiMedx price target lowered to $7 from $10 at Citizens

MiMedx price target lowered to $7 from $10 at Citizens

2026-04-17T19:06:41.000Z - 4 weeks ago

MiMedx price target lowered to $7 from $10 at Citizens

MiMedx price target lowered to $6 from $10 at Northland

2026-04-17T13:24:00.000Z - 4 weeks ago

MiMedx price target lowered to $6 from $10 at Northland

MiMedx price target lowered to $7 from $10 at Craig-Hallum

2026-04-17T13:10:22.000Z - 4 weeks ago

MiMedx price target lowered to $7 from $10 at Craig-Hallum

MiMedx announces restructuring, cost reduction initiatives

2026-04-16T13:23:44.000Z - 4 weeks ago

MiMedx announces restructuring, cost reduction initiatives

MIMEDX Announces Restructuring and Cost Reduction Initiative

Apr 16, 2026, 8:00 AM EDT - 4 weeks ago

MIMEDX Announces Restructuring and Cost Reduction Initiative

MIMEDX to Sponsor Leading Advanced Wound Care Conferences

Apr 2, 2026, 9:15 AM EDT - 6 weeks ago

MIMEDX to Sponsor Leading Advanced Wound Care Conferences

MIMEDX Announces Launch of CHORIOFIX™

Mar 23, 2026, 8:00 AM EDT - 7 weeks ago

MIMEDX Announces Launch of CHORIOFIX™

MiMedx announces commercial launch of AMNIOFIX Thyroid Shields

2026-03-05T13:20:46.000Z - 2 months ago

MiMedx announces commercial launch of AMNIOFIX Thyroid Shields

MIMEDX Expands Surgical Product Portfolio with the Launch of AMNIOFIX® Thyroid Shields

Mar 5, 2026, 8:00 AM EST - 2 months ago

MIMEDX Expands Surgical Product Portfolio with the Launch of AMNIOFIX® Thyroid Shields

MiMedx Group Earnings Call Transcript: Q4 2025

Feb 25, 2026, 4:30 PM EST - 2 months ago

MiMedx Group Earnings Call Transcript: Q4 2025

MiMedx reports Q4 adjusted EPS 14c, consensus 11c

2026-02-25T21:06:51.000Z - 2 months ago

MiMedx reports Q4 adjusted EPS 14c, consensus 11c

MiMedx sees FY26 revenue $340M-$360M, consensus $356.17M

2026-02-25T21:05:57.000Z - 2 months ago

MiMedx sees FY26 revenue $340M-$360M, consensus $356.17M

MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results

Feb 25, 2026, 4:01 PM EST - 2 months ago

MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results

MiMedx initiated with an Outperform at Citizens

2026-02-23T09:45:23.000Z - 2 months ago

MiMedx initiated with an Outperform at Citizens

MiMedx price target lowered to $8 from $12 at Cantor Fitzgerald

2026-02-17T13:15:52.000Z - 3 months ago

MiMedx price target lowered to $8 from $12 at Cantor Fitzgerald

MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25

Feb 17, 2026, 8:00 AM EST - 3 months ago

MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25

MiMedx announces distribution agreement with Summit Products Group

2026-02-04T15:30:14.000Z - 3 months ago

MiMedx announces distribution agreement with Summit Products Group

MIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical & Wound Products

Feb 4, 2026, 10:27 AM EST - 3 months ago

MIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical & Wound Products

MIMEDX Celebrates 15 Year Anniversary of EPIFIX® and AMNIOFIX®

Feb 2, 2026, 8:00 AM EST - 3 months ago

MIMEDX Celebrates 15 Year Anniversary of EPIFIX® and AMNIOFIX®

MiMedx price target lowered to $10 from $13 at Craig-Hallum

2026-01-23T14:16:32.000Z - 4 months ago

MiMedx price target lowered to $10 from $13 at Craig-Hallum

MiMedx price target lowered to $10 from $12 at Northland

2026-01-20T14:10:19.000Z - 4 months ago

MiMedx price target lowered to $10 from $12 at Northland

MiMedx price target lowered to $10 from $12 at Lake Street

2026-01-20T13:51:36.000Z - 4 months ago

MiMedx price target lowered to $10 from $12 at Lake Street

MiMedx enters agreement with Regen Lab to distribute RegenKit-WoundGel in U.S.

2025-12-22T14:50:35.000Z - 5 months ago

MiMedx enters agreement with Regen Lab to distribute RegenKit-WoundGel in U.S.

MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel

Dec 22, 2025, 9:43 AM EST - 5 months ago

MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel

MIMEDX Provides Update on EPIEFFECT® Randomized Controlled Trial

Nov 13, 2025, 8:00 AM EST - 6 months ago

MIMEDX Provides Update on EPIEFFECT® Randomized Controlled Trial

MIMEDX to Participate in Upcoming Investor Conferences

Nov 10, 2025, 4:01 PM EST - 6 months ago

MIMEDX to Participate in Upcoming Investor Conferences

MIMEDX Comments on CY 2026 Medicare Physician Fee Schedule Final Rule

Nov 3, 2025, 9:15 AM EST - 6 months ago

MIMEDX Comments on CY 2026 Medicare Physician Fee Schedule Final Rule

MiMedx Group Earnings Call Transcript: Q3 2025

Oct 29, 2025, 4:30 PM EDT - 7 months ago

MiMedx Group Earnings Call Transcript: Q3 2025

MIMEDX Announces Record Revenue for Third Quarter 2025

Oct 29, 2025, 4:01 PM EDT - 7 months ago

MIMEDX Announces Record Revenue for Third Quarter 2025

MIMEDX to Host Third Quarter 2025 Operating and Financial Results Conference Call on October 29

Oct 15, 2025, 8:00 AM EDT - 7 months ago

MIMEDX to Host Third Quarter 2025 Operating and Financial Results Conference Call on October 29

MIMEDX Announces Launch of EPIXPRESS®

Oct 6, 2025, 9:28 AM EDT - 7 months ago

MIMEDX Announces Launch of EPIXPRESS®

MiMedx Group Transcript: Cantor Global Healthcare Conference 2025

Sep 3, 2025, 1:35 PM EDT - 9 months ago

MiMedx Group Transcript: Cantor Global Healthcare Conference 2025

MIMEDX to Sponsor and Attend Symposium on Advanced Wound Care (SAWC) Fall

Sep 3, 2025, 8:00 AM EDT - 9 months ago

MIMEDX to Sponsor and Attend Symposium on Advanced Wound Care (SAWC) Fall

MiMedx Group Earnings Call Transcript: Q2 2025

Jul 30, 2025, 4:30 PM EDT - 10 months ago

MiMedx Group Earnings Call Transcript: Q2 2025

MIMEDX Announces Record Second Quarter 2025 Operating and Financial Results

Jul 30, 2025, 4:01 PM EDT - 10 months ago

MIMEDX Announces Record Second Quarter 2025 Operating and Financial Results

MIMEDX Announces Strategic Collaboration with Vaporox, Inc.

Jul 30, 2025, 8:00 AM EDT - 10 months ago

MIMEDX Announces Strategic Collaboration with Vaporox, Inc.

MIMEDX to Host Second Quarter 2025 Operating and Financial Results Conference Call on July 30

Jul 16, 2025, 8:00 AM EDT - 10 months ago

MIMEDX to Host Second Quarter 2025 Operating and Financial Results Conference Call on July 30

MIMEDX Comments on Proposed Medicare Reimbursement Rule Changes for CY 2026

Jul 15, 2025, 9:15 AM EDT - 10 months ago

MIMEDX Comments on Proposed Medicare Reimbursement Rule Changes for CY 2026

MiMedx Group Transcript: BofA Securities 2025 Healthcare Conference

May 13, 2025, 8:15 PM EDT - 1 year ago

MiMedx Group Transcript: BofA Securities 2025 Healthcare Conference

MIMEDX to Present at the BofA Securities 2025 Healthcare Conference

May 6, 2025, 8:00 AM EDT - 1 year ago

MIMEDX to Present at the BofA Securities 2025 Healthcare Conference

MIMEDX Announces Publication of Health Economics Data in Mohs Micrographic Surgery (MMS)

May 5, 2025, 8:30 AM EDT - 1 year ago

MIMEDX Announces Publication of Health Economics Data in Mohs Micrographic Surgery (MMS)

MiMedx Group Earnings Call Transcript: Q1 2025

Apr 30, 2025, 4:30 PM EDT - 1 year ago

MiMedx Group Earnings Call Transcript: Q1 2025

MIMEDX Announces First Quarter 2025 Operating and Financial Results

Apr 30, 2025, 4:01 PM EDT - 1 year ago

MIMEDX Announces First Quarter 2025 Operating and Financial Results

MIMEDX to Feature Growing Body of Clinical and Scientific Evidence at Upcoming Wound & Surgical-Focused Industry Conferences

Apr 10, 2025, 4:01 PM EDT - 1 year ago

MIMEDX to Feature Growing Body of Clinical and Scientific Evidence at Upcoming Wound & Surgical-Focused Industry Conferences

MiMedx Group Transcript: TD Cowen 45th Annual Healthcare Conference

Mar 4, 2025, 11:10 AM EST - 1 year ago

MiMedx Group Transcript: TD Cowen 45th Annual Healthcare Conference

MIMEDX to Present at TD Cowen 45th Annual Health Care Conference

Feb 27, 2025, 8:00 AM EST - 1 year ago

MIMEDX to Present at TD Cowen 45th Annual Health Care Conference

MiMedx Group Earnings Call Transcript: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

MiMedx Group Earnings Call Transcript: Q4 2024

MIMEDX Announces Fourth Quarter and Full Year 2024 Operating and Financial Results

Feb 26, 2025, 4:01 PM EST - 1 year ago

MIMEDX Announces Fourth Quarter and Full Year 2024 Operating and Financial Results

MiMedx Group Transcript: Stifel 2024 Healthcare Conference

Nov 18, 2024, 9:45 AM EST - 1 year ago

MiMedx Group Transcript: Stifel 2024 Healthcare Conference

MIMEDX's Advocacy to Rein in Runaway Medicare Spend for Skin Substitutes Has Yielded Significant Results with Planned Implementation of LCDs

Nov 14, 2024, 9:15 AM EST - 1 year ago

MIMEDX's Advocacy to Rein in Runaway Medicare Spend for Skin Substitutes Has Yielded Significant Results with Planned Implementation of LCDs

MiMedx Group Earnings Call Transcript: Q3 2024

Oct 30, 2024, 4:30 PM EDT - 1 year ago

MiMedx Group Earnings Call Transcript: Q3 2024

MIMEDX Announces Third Quarter 2024 Operating and Financial Results

Oct 30, 2024, 4:01 PM EDT - 1 year ago

MIMEDX Announces Third Quarter 2024 Operating and Financial Results

MIMEDX to Host Third Quarter 2024 Operating and Financial Results Conference Call on October 30

Oct 14, 2024, 8:00 AM EDT - 1 year ago

MIMEDX to Host Third Quarter 2024 Operating and Financial Results Conference Call on October 30

MIMEDX Points to The New York Times Article on the Vast Benefits of Placental Tissue

Oct 8, 2024, 4:01 PM EDT - 1 year ago

MIMEDX Points to The New York Times Article on the Vast Benefits of Placental Tissue

MIMEDX Showcases Leading Allograft Portfolio and Its Latest Scientific and Clinical Evidence at SAWC Fall

Oct 1, 2024, 4:01 PM EDT - 1 year ago

MIMEDX Showcases Leading Allograft Portfolio and Its Latest Scientific and Clinical Evidence at SAWC Fall

MiMedx Group Transcript: 2024 Cantor Fitzgerald Global Healthcare Conference

Sep 18, 2024, 8:00 AM EDT - 1 year ago

MiMedx Group Transcript: 2024 Cantor Fitzgerald Global Healthcare Conference

EX-MiMEDX EMPLOYEES ALLEGE MiMEDX "PRESSURE[D] HEALTHCARE PROVIDERS TO TREAT WOUNDED VETERANS, DIABETICS, CHRONIC WOUND SUFFERERS, AND OTHER PATIENTS WITH MEDICALLY UNNECESSARY OR UNSUITABLE PRODUCTS"

Sep 11, 2024, 1:03 PM EDT - 1 year ago

EX-MiMEDX EMPLOYEES ALLEGE MiMEDX "PRESSURE[D] HEALTHCARE PROVIDERS TO TREAT WOUNDED VETERANS, DIABETICS, CHRONIC WOUND SUFFERERS, AND OTHER PATIENTS WITH MEDICALLY UNNECESSARY OR UNSUITABLE PRODUCTS"

THIRD DEFENDANT FIGHTS BACK AGAINST MiMEDX, CLAIMING 'DISREPUTABLE AND UNLAWFUL BUSINESS PRACTICES'

Sep 4, 2024, 4:23 PM EDT - 1 year ago

THIRD DEFENDANT FIGHTS BACK AGAINST MiMEDX, CLAIMING 'DISREPUTABLE AND UNLAWFUL BUSINESS PRACTICES'

DEFENDANT FIGHTS BACK AGAINST MiMEDX "BLATANT INTIMIDATION" NON-COMPETE SUIT

Aug 26, 2024, 9:30 AM EDT - 1 year ago

DEFENDANT FIGHTS BACK AGAINST MiMEDX "BLATANT INTIMIDATION" NON-COMPETE SUIT

MiMedx Group Earnings Call Transcript: Q2 2024

Jul 31, 2024, 4:30 PM EDT - 1 year ago

MiMedx Group Earnings Call Transcript: Q2 2024

MIMEDX Announces Launch of HELIOGEN™ Fibrillar Collagen Matrix

Jul 31, 2024, 4:02 PM EDT - 1 year ago

MIMEDX Announces Launch of HELIOGEN™ Fibrillar Collagen Matrix

MIMEDX Announces Second Quarter 2024 Operating and Financial Results

Jul 31, 2024, 4:01 PM EDT - 1 year ago

MIMEDX Announces Second Quarter 2024 Operating and Financial Results

MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature – Scientific Reports

Jul 22, 2024, 8:10 AM EDT - 1 year ago

MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature – Scientific Reports

MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer

Jun 26, 2024, 4:01 PM EDT - 2 years ago

MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer

MiMedx Group Earnings Call Transcript: Q1 2024

Apr 30, 2024, 4:30 PM EDT - 2 years ago

MiMedx Group Earnings Call Transcript: Q1 2024

MIMEDX Announces First Quarter 2024 Operating and Financial Results

Apr 30, 2024, 4:01 PM EDT - 2 years ago

MIMEDX Announces First Quarter 2024 Operating and Financial Results

MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30

Apr 16, 2024, 8:00 AM EDT - 2 years ago

MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30

MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing

Mar 20, 2024, 7:00 AM EDT - 2 years ago

MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing

MiMedx Group Transcript: TD Cowen 44th Annual Health Care Conference

Mar 4, 2024, 2:10 PM EST - 2 years ago

MiMedx Group Transcript: TD Cowen 44th Annual Health Care Conference

MiMedx Group Earnings Call Transcript: Q4 2023

Feb 28, 2024, 4:30 PM EST - 2 years ago

MiMedx Group Earnings Call Transcript: Q4 2023

MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results

Feb 28, 2024, 4:01 PM EST - 2 years ago

MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results

MIMEDX to Present at TD Cowen 44th Annual Health Care Conference

Feb 20, 2024, 8:00 AM EST - 2 years ago

MIMEDX to Present at TD Cowen 44th Annual Health Care Conference

MIMEDX to Host Fourth Quarter and Full Year 2023 Operating and Financial Results Conference Call on February 28

Feb 12, 2024, 8:00 AM EST - 2 years ago

MIMEDX to Host Fourth Quarter and Full Year 2023 Operating and Financial Results Conference Call on February 28

Mobagri
Mobagri May. 15 at 4:32 AM
$MDXG this guy has no business being here. He was hired in 2023 to be PR for this losing company
2 · Reply
WarrenDouglasTrader
WarrenDouglasTrader May. 14 at 8:38 PM
$MDXG Legislative changes are coming.
0 · Reply
Monticello4
Monticello4 May. 14 at 7:49 PM
$MDXG ...-=
0 · Reply
Monticello4
Monticello4 May. 14 at 7:48 PM
$MDXG ===
0 · Reply
Monticello4
Monticello4 May. 14 at 7:45 PM
$MDXG .....
0 · Reply
Monticello4
Monticello4 May. 14 at 7:45 PM
$MDXG -.-
0 · Reply
Monticello4
Monticello4 May. 14 at 7:44 PM
$MDXG #
0 · Reply
Monticello4
Monticello4 May. 14 at 7:44 PM
$MDXG -
0 · Reply
Monticello4
Monticello4 May. 14 at 7:43 PM
$MDXG +dxcm
0 · Reply
Monticello4
Monticello4 May. 14 at 7:43 PM
$MDXG -=-
0 · Reply
Monticello4
Monticello4 May. 14 at 7:42 PM
$MDXG =orgo
0 · Reply
Monticello4
Monticello4 May. 14 at 7:41 PM
$MDXG .msft
0 · Reply
Mobagri
Mobagri May. 14 at 7:20 PM
$MDXG
0 · Reply
Monticello4
Monticello4 May. 14 at 6:43 PM
$MDXG -,,-
0 · Reply
Monticello4
Monticello4 May. 14 at 6:42 PM
$MDXG ...
0 · Reply
Monticello4
Monticello4 May. 14 at 6:41 PM
$MDXG ..
0 · Reply
Monticello4
Monticello4 May. 14 at 6:40 PM
$MDXG .
0 · Reply
Mobagri
Mobagri May. 13 at 9:14 PM
$MDXG gunny the star employee
1 · Reply
Monticello4
Monticello4 May. 13 at 8:17 PM
$MDXG ...
1 · Reply
Monticello4
Monticello4 May. 13 at 7:05 PM
$MDXG ...🤣
0 · Reply
Monticello4
Monticello4 May. 13 at 5:26 PM
$MDXG ...
0 · Reply
NVDAMillionaire
NVDAMillionaire May. 13 at 5:15 PM
$MDXG Outstanding article that hits the mark on MDXG's current state. So if you want to refresh your MDXG insights or learn about MDXG from scratch, this is a must read. https://everyticker.com/quote/MDXG/analysis/mimedx-when-surgical-growth-meets-wound-care-chaos-value-emerges-nasdaq-mdxg
2 · Reply